Beside the alteration of psoriasis biomarkers, we documented in imiquimod-treated mouse CRBPI-knockout skin a more evident reduced expression of other retinoid binding proteins, such as CRABPII and RXRα. This evidence concerns the gene RBP1 and psoriasis.